Helaina Raises $45M to Commercialize First Precision-Fermented Human Lactoferrin
US precision fermentation company Helaina has raised $45 million in Series B funding to scale and commercialize its first product, effera Human Lactoferrin. Effera, claimed to be the first and only human lactoferrin available, is a bioactive ingredient that supports women’s health, active nutrition, and healthy aging. According to the startup, clinical and pre-clinical research indicates it is even more effective than bovine lactoferrin. The round, led by Avidity Partners, …
New York’s Helaina Ready to Commercialize Animal-Free Lactoferrin
After achieving a large-scale manufacturing milestone, bioactive protein company Helaina announces that its first high-value ingredient —animal-free lactoferrin — is ready for commercialization to create consumer products focused on immune health. Founded in 2019 in New York City, Helaina has raised more than $25 million from leading investors. Helaina is a member of the Precision Fermentation Alliance, a new trade organization formed to promote precision fermentation as a solution for …
9 Global Food Tech Leaders Join Forces to Launch The Precision Fermentation Alliance
Today, nine leaders in precision fermentation announce they are coming together to establish the Precision Fermentation Alliance, a new trade organization to promote precision fermentation as a solution for a more resilient and sustainable food system. Intended to serve as an industry voice for the precision fermentation industry, the group’s founding members include Change Foods, The EVERY Co., Helaina, Imagindairy, Motif FoodWorks, New Culture, Onego Bio, Perfect Day, and Remilk. …